Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting after a semaglutide injection is one of the most common side effects reported in clinical trials, affecting a meaningful proportion of participants in the STEP programme, and it tends to hit hardest in the early weeks of treatment or after a dose increase. It happens because semaglutide slows the rate at which your stomach empties, and your gut takes time to adjust to that change. The medicines page on the NHS explains semaglutide's GI side effects clearly: nausea and vomiting are listed as very common, meaning they affect more than one person in ten. That doesn't make it pleasant, but it does make it predictable — and manageable for most people once they know what's driving it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, enrolled over 1,900 adults taking semaglutide 2.4mg weekly for 68 weeks. Nausea and vomiting were among the most frequently reported adverse events in the active group, with vomiting occurring in roughly a quarter of participants at some point during treatment, compared with far fewer in the placebo arm. The majority of these episodes were mild to moderate in severity and were concentrated early in treatment or during dose escalation. That pattern matters: if you are trying to understand why Wegovy makes some people throw up, it helps to know that episodes in week two are, statistically, a very different situation from still vomiting at week twelve on a stable dose. Clinicians use the escalation schedule partly for this reason. Starting at 0.25mg and stepping up gradually gives the gastrointestinal tract time to recalibrate, and many people who experience vomiting at a lower dose find it settles before the next increase. If you want a broader view of how semaglutide works in the body, the semaglutide overview covers the mechanism in plain terms.
Semaglutide reaches peak plasma concentration roughly 24 to 72 hours after a subcutaneous injection, which is why many people feel fine on injection day and feel dreadful the morning after. If you feel worse about a day after your Wegovy shot, you are not imagining it — the timing is pharmacologically predictable. Our page on the day after a Wegovy shot goes into this window in more detail. Gastric emptying slows substantially at peak drug levels, so the stomach holds onto whatever was eaten for longer than usual. Combined with the appetite suppression semaglutide produces centrally, this creates conditions where even a normal-sized meal can sit heavily and trigger nausea that tips into vomiting. Certain foods make this considerably more likely: high-fat meals, very rich dishes, dairy-heavy foods and large portions all increase gastric residence time further. The interaction between dairy and Wegovy is something patients ask about regularly, and for good reason, cheese, cream and full-fat milk seem to be particular culprits for some people during the early weeks.
The evidence base for lifestyle modifications alongside GLP-1 treatment is not enormous, but clinical experience is consistent and NHS guidance reflects it. Eating smaller portions more frequently, putting utensils down between bites, avoiding lying flat for at least an hour after eating, and cutting back on fried and fatty foods all reduce the severity of GI symptoms in most patients. Staying well hydrated is important too, since repeated vomiting risks dehydration, which then worsens nausea in a feedback loop. Cold or room-temperature fluids are usually better tolerated than hot drinks straight after an injection day. If you are finding that throwing up after semaglutide is disrupting meals altogether, it is worth reading through the experiences documented on vomiting on Wegovy to see which patterns others have found manageable. Some people also notice they are specifically bringing up bile rather than food, which has its own distinct causes, our page on throwing up bile on Wegovy covers that specifically. Knowing the difference matters clinically.
There is a meaningful difference between unpleasant and dangerous. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines, you can report any suspected side effects, including persistent vomiting, through the MHRA Yellow Card scheme. The warning sign to act on immediately is severe stomach pain (particularly pain that radiates through to the back) especially when combined with vomiting. That combination requires urgent medical review, not self-management at home. You should also seek help promptly if vomiting means you cannot keep fluids down for more than 24 hours, if you see blood in vomit, or if you develop signs of dehydration such as dizziness, very dark urine or feeling faint. Mild, self-limiting vomiting in the first days after an injection is within the expected profile of treatment. Prolonged or severe vomiting is not. If you are unsure where your experience sits, the patient FAQs cover some common questions, and the free consultation with one of our prescribers is the right place to discuss your specific situation, a real clinician reviews every consultation the same day, not a decision tree.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.